Dr James Cameron
Dr James Cameron is a Director of the Queensland Cardiovascular Group and member of the combined Wesley, St Andrew's Research Unit. His special interests are in Coronary Angiography, Coronary Angioplasty and stenting, Patent Foramen Ovale and Atrial Septal Defect Closure.
Dr Cameron is a First Class Honours Graduate from the University of Queensland in Medicine and has a Fellowship to the Royal College of Physicians in Cardiology. Following completion of postgraduate training, Dr Cameron undertook a two year clinical and research training fellowship in the United States, attending both New England Medicine Centre in Boston and Stanford University Medical Centre in Palo Alto, California.
Currently, Dr Cameron is a Visiting Medical Officer at St Andrews Hospital and Mater Private Hospital.
Dr Cameron is past President of Cardiac Society of Australia and New Zealand and is Chair Australasian Cardiac Outcomes Registry. His research interests include statistical process control methods in assessing cardiovascular procedural outcomes.
Prof Clara Chow
Professor Clara Chow is a clinician-scientist (Cardiologist). She is Professor of Medicine, University of Sydney and Program Director of Community Based Cardiac Services at Westmead Hospital. Clara is the Academic Director of Westmead Applied Research Centre, University of Sydney.
She holds honorary posts as the Academic co-Director of Charles Perkins Centre Westmead (2016), co-lead of the Cardiovascular stream of Sydney Health Partners, and honorary professorial fellow at the George Institute for Global Health.
She is currently on the Board and Honorary Secretary of the Cardiac Society of Australia and New Zealand, a member of the PBAC and a Steering Committee member of the World Heart Federation, Emerging Leaders Programme.
Prof Chow is the recipient of a number of awards including the Google Impact Challenge Award 2016, which supports non-profit innovators using technology to tackle the world's biggest social challenges.
Prof Richmond Jeremy
Professor Richmond Jeremy's medical and cardiology training were at the University of Sydney and Royal Prince Alfred Hospital.
His clinical research career includes a PhD on coronary physiology and a postdoctoral research Fellowship at Johns Hopkins Hospital, Baltimore before returning to the University of Sydney and Royal Prince Alfred Hospital.
University of Sydney responsibilities have included service as Associate Dean Sydney, Medical School, Head of Central Clinical School and Pro Vice-Chancellor, Campus Infrastructure and Services.
Professional responsibilities have included service as Editor-in-Chief of Heart Lung and Circulation, membership of Boards on National Heart Foundation (NSW), Royal Australasian College of Physicians (Adult Medicine Division) and Cardiac Society of Australia and New Zealand.
Dr Andrew Kerr
Andrew is a cardiologist at Middlemore Hospital and Honorary Academic at the University of Auckland. He has led the development and implementation of Acute PREDICT (the hospital-based version of the PREDICT tool).
He was a member of the clinical governance group overseeing the translation of CVD risk management guidelines into the PREDICT web-based decision support and was co-clinical lead of the Heart Forecast tool that facilitates patient-clinician risk communication.
Andrew leads the All New Zealand Acute Coronary Syndrome (ANZACS) stream of the VIEW programme and is Chair of the ANZACS-QI governance group.
A/Prof Andrew MacIsaac
Andrew MacIsaac is the Director of Cardiology at St Vincent’s hospital Melbourne, an Association Professor in the University of Melbourne’s Department of Medicine at St Vincent’s Hospital Melbourne and Adjunction Professor of Medicine at Australian Catholic University.
His cardiology training was at St Vincent’s and Prince Henry’s Hospitals and he then undertook Fellowships in Interventional Cardiology at the Cleveland Clinic, Cleveland, Ohio, USA and then Stanford University Medical Centre, California.
His clinical interests include management of acute cardiac conditions, interventional cardiology and valvular heart disease. He has active research interests in coronary, pulmonary vascular physiology and indigenous health.
Prof Tom Marwick
Thomas Marwick is the Director and Chief Executive of the Baker Heart and Diabetes Institute. He is also a foundation member of the Australian Academy of Health and Medical Sciences, recipient of personal awards and honours (including the Eccles award of the National Health and Medical Research Council of Australia), associate editor of the Journal of the American College of Cardiology (JACC), deputy editor of JACC-Cardiovascular Imaging, and former Chair of the Heart Foundation's National Research Committee. He was previously Director of the Menzies Institute for Medical Research in Tasmania.
Prof Andrew McGavigan
Professor McGavigan graduated from the University of Glasgow in the United Kingdom and undertook postgraduate studies both in the UK and Australia. In 2003, he completed a Doctorate of Medicine (MD), which was conferred by the University of Glasgow. He then completed training in cardiac electrophysiology at Glasgow Royal Infirmary in the United Kingdom and the Royal Melbourne Hospital, Australia, prior to taking up a post as a Staff Specialist at Flinders Medical Centre in 2007. He is the Director of Cardiac Electrophysiology and Pacing for the Southern Area Local Healthcare Network.
Prof McGavigan is recognized as a clinical expert in the assessment of palpitations, arrhythmias, syncope and sudden death. He has expertise in all aspects of non-invasive and invasive cardiac electrophysiology, including electrophysiological studies, simple and complex radiofrequency ablation and the implantation and follow-up of device therapy for bradycardia, tachycardia and heart failure. He has a particular clinical interest in catheter ablation of atrial fibrillation.
Prof McGavigan is Professor of Cardiovascular Medicine at Flinders University and is the author of more than 50 clinical papers, reviews and book chapters in addition to an extensive number of published abstracts. He is actively involved in national and international clinical trials. He is a Board Member of the Cardiac Society of Australia and New Zealand, Chair of the Electrophysiology and Pacing Council of CSANZ and a Board Member of the Australasian Cardiac Outcomes Registry.
Dr Aravinda Thiagalingam
Dr Aravinda Thiagalingam is currently a staff specialist cardiologist in Westmead Hospital and Director of Echocardiography for the Central and Eastern Clusters of Sydney West Area Health Service.
He completed his Medical degree and basic physician training at Wellington Hospital/Otago University and his advanced training in Cardiology at Royal Prince Alfred Hospital. He performed his PhD research in cardiac electrophysiology in Westmead Hospital under the supervision of Professor David Ross and Associate Professor Pramesh Kovoor.
He was then awarded the Neil Hamilton Fairley/ Ralph Reader NHMRC/NHF overseas fellowship to perform postdoctoral research in Cardiac Imaging and Cardiac Electrophysiology in Massachusetts General Hospital/ Harvard Medical School.
Steering Committee Chairs
Prof David Brieger
Cardiovascular Procedures Registry
Professor David Brieger is an interventional cardiologist and head of the coronary care and coronary interventions at Concord Hospital and Professor of Cardiology, University of Sydney. His particular clinical interests include coronary disease and atrial fibrillation and he practices across the full spectrum of cardiac disease.
He maintains an active research interest in new antithrombotic drugs for cardiac conditions, and the promotion of high quality care for patients during and following their hospitalization.
Prof Darren Walters
Professor Darren Walters has been the Director of Cardiology at The Prince Charles Hospital from 2005, an Interventional Cardiologist from 2001, and Executive Chair of the Prince Charles Hospital Heart and Lung Clinical stream from 2014 – 2017.
He was trained at The Prince Charles Hospital and then as a Clinical and Research Fellow in Interventional Cardiology at Massachusetts General Hospital, Harvard Medical School, Boston 2000-2001. He is a Professor of Medicine University of Queensland, and a graduate of the UQ Medical School.
He is involved in International prospective randomised trials and investigator driven translational research in interventional cardiology and is the author of more than 200 peer reviewed papers, abstracts and book chapters. He has been an invited expert in more than half a dozen countries overseas including the USA, Europe, Japan, Hong Kong, Malaysia, Thailand, Korea, India, Singapore and China.